MAB1257

antibody from R&D Systems

Targeting: FCGR1A CD64, CD64A

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Antibody Data

Product number

MAB1257

Provider

R&D Systems

Product name

Anti-Human Fc gamma RI/CD64 Monoclonal Antibody (Clone 10.1)

Antibody type

Monoclonal

Antigen

Rheumatoid synovial fluid cells and human monocyte-derived fibronectin

Description

Protein A or G purified from hybridoma culture supernatant

Reactivity

Human

Host

Mouse

Isotype

IgG

Vial size

500 µg

References

Submitted references

Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.

McWilliams EM, Mele JM, Cheney C, Timmerman EA, Fiazuddin F, Strattan EJ, Mo X, Byrd JC, Muthusamy N, Awan FT
Oncoimmunology 2016;5(10):e1226720

---

Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.

He X, Sun X, Wang J, Wang X, Zhang Q, Tzipori S, Feng H
Infection and immunity 2009 Jun;77(6):2294-303

---

Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies.

Schleinitz N, Cognet C, Guia S, Laugier-Anfossi F, Baratin M, Pouget J, Pelissier JF, Harle JR, Vivier E, Figarella-Branger D
Arthritis and rheumatism 2008 Oct;58(10):3216-23

---

Excessive exposure to anionic surfaces maintains autoantibody response to beta(2)-glycoprotein I in patients with antiphospholipid syndrome.

Yamaguchi Y, Seta N, Kaburaki J, Kobayashi K, Matsuura E, Kuwana M
Blood 2007 Dec 15;110(13):4312-8